{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antiviral agents", "COVID-19", "Inflammation", "Psidium guajava"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37009425", "DateRevised": {"Year": "2023", "Month": "04", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "03", "Day": "07"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jsps.2023.02.012"], "Journal": {"ISSN": "1319-0164", "JournalIssue": {"Volume": "31", "Issue": "4", "PubDate": {"Year": "2023", "Month": "Apr"}}, "Title": "Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society", "ISOAbbreviation": "Saudi Pharm J"}, "ArticleTitle": "The effect of <i>Psidium guajava</i> Leaves' extract for mild and asymptomatic corona virus Disease-19.", "Pagination": {"StartPage": "592", "EndPage": "596", "MedlinePgn": "592-596"}, "Abstract": {"AbstractText": ["COVID-19 is an emerging disease that attacks the respiratory and systemic systems. Various treatments have been used for COVID-19, but no antiviral agents seemed to be efficacious. Many medicinal plants are commonly used for viral infections in Indonesia, including the guajava leaf. The study aimed to determine the effects of <i>Psidium guajava</i> extract supplementation on inflammation markers of asymptomatic and mild COVID-19 patients. The conversion time of PCR results was also evaluated. This study was an experimental, single-blinded, randomized clinical trial (ClinicalTrials.gov: NCT04810728) comparing the efficacy of <i>P. guajava</i> extract at the dose of 1000\u00a0mg/8h on top of standard treatment with the standard treatment only for asymptomatic and mild COVID-19 subjects. The primary endpoints were neutrophil and lymphocyte percentages as well as the neutrophil/lymphocyte ratio (NLR) on day 7 of the treatment. The secondary endpoints were high-sensitivity c-reactive protein (hs-CRP) level, PCR-based conversion time, and recovery rate at weeks 2 and 4. A total of 90 subjects were enrolled, and there were 40 subjects in the <i>P. guajava</i> (experimental) group and 41 subjects in the control group who completed the research. On day 7, significantly lower percentage of neutrophil (52.4% vs 58.9%, <i>p</i>\u00a0=\u00a00.002), higher lymphocyte percentage (35.5%, vs 29.7%, <i>p</i>\u00a0=\u00a00.002), and lower NLR (1.5 vs 2.1, <i>p</i>\u00a0=\u00a00.001) were demonstrated in the experimental versus control group. The PCR-based conversion time was shorter (14\u00a0days vs 16\u00a0days, <i>p</i>\u00a0<\u00a00.001), and recovery rate at 2 and 4\u00a0weeks were higher (49% vs 27%, <i>p</i>\u00a0=\u00a00.03 and 100% vs 82%, <i>p</i>\u00a0=\u00a00.003, respectively) in the experimental group. There were no differences in the baseline characteristics. <i>P. guajava</i> extract supplementation reduced neutrophil and increased lymphocyte percentages which led to reduced NLR, accelerated PCR-based conversion time, and increased recovery rate in subjects with mild and asymptomatic COVID-19 infection.\\."], "CopyrightInformation": "\u00a9 2023 The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Universitas Baiturrahmah, 25586 Padang, Indonesia."}], "LastName": "Heppy", "ForeName": "Fredia", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Universitas Andalas, 25127 Padang, Indonesia."}], "LastName": "Mulyana", "ForeName": "Roza", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Universitas Andalas, 25127 Padang, Indonesia."}], "LastName": "Afrainin Syah", "ForeName": "Nur", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dexa Laboratories of Biomolecular Science, Dexa Medica Group, 17530 Cikarang, Indonesia."}], "LastName": "Tjandrawinata", "ForeName": "Raymond R", "Initials": "RR"}], "DataBankList": [{"DataBankName": "ClinicalTrials.gov", "AccessionNumberList": ["NCT04810728"]}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Saudi Arabia", "MedlineTA": "Saudi Pharm J", "NlmUniqueID": "9705695", "ISSNLinking": "1319-0164"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Borba, M.G.S., Val, F.F.A., Sampaio, V.S., Alexandre, M.A.A., Melo, G.C., Brito, M., Mour\u00e3o, M.P.G., Brito-Sousa, J.D., Ba\u00eda-da-Silva, D., Guerra, M.V.F., Hajjar, L.A., Pinto, R.C., Balieiro, A.A.S., Pacheco, A,G.F., Santos, J.D.O. Jr, Naveca, F.G., Xavier, M.S., Siqueira, A.M., Schwarzbold, A., Croda, J., Nogueira, M.L., Romero, G.A.S., Bassat, Q., Fontes, C.J., Albuquerque, B.C., Daniel-Ribeiro, C.T., Monteiro, W.M., Lacerda, M.V.G., CloroCovid-19 Team., 2020. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. JAMA Netw Open. 3,e208857-e208857. https://doi.org/10.1001/jamanetworkopen.2020.8857.", "ArticleIdList": ["32330277"]}, {"Citation": "Cao B., Wang Y., Wen D., Liu W., Wang J., Fan G., Ruan L., Song B., Cai Y., Wei M., Li X., Xia J., Chen N., Xiang J., Yu T., Bai T., Xie X., Zhang L., Li C., Yuan Y., Chen H., Li H., Huang H., Tu S., Gong F., Liu Y., Wei Y., Dong C., Zhou F., Gu X., Xu J., Liu Z., Zhang Y., Li H., Shang L., Wang K., Li K., Zhou X., Dong X., Qu Z., Lu S., Hu X., Ruan S., Luo S., Wu J., Peng L., Cheng F., Pan L., Zou J., Jia C., Wang J., Liu X., Wang S., Wu X., Ge Q., He J., Zhan H., Qiu F., Guo L., Huang C., Jaki T., Hayden F.G., Horby P.W., Zhang D., Wang C. A trial of lopinavir\u2013ritonavir in adults hospitalized with severe COVID-19. N. Engl. J. Med. 2020;382:1787\u20131799. doi: 10.1056/nejmoa2001282.", "ArticleIdList": ["10.1056/nejmoa2001282", "PMC7121492", "32187464"]}, {"Citation": "Cavalcante-Silva L., Carvalho D., Lima \u00c9.A., Galv\u00e3o J., da Silva J., Sales-Neto J.M., Rodrigues-Mascarenhas S. Neutrophils and COVID-19: The road so far. Int Immunopharmacol. 2021;90 doi: 10.1016/j.intimp.2020.107233.", "ArticleIdList": ["10.1016/j.intimp.2020.107233", "PMC7703515", "33290963"]}, {"Citation": "Cushnie T., Lamb A.J. Recent advances in understanding the antibacterial propoerties of flavonoids. Int. J. Antimicrob Agents. 2011;2011 doi: 10.1016/j.ijantimicag.2011.02.014.", "ArticleIdList": ["10.1016/j.ijantimicag.2011.02.014", "21514796"]}, {"Citation": "da Silva, F., da Silva, K., de Oliveira, L., Costa, E. V., Koolen, H. H., Pinheiro, M., de Souza, A., de Souza, A., 2020. Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-Cov-2 main protease (Mpro) and RNA-dependent RNA polymerase. Mem. Inst. Oswaldo. Cruz. 115: e200207. https://doi.org/10.1590/0074-02760200207.", "ArticleIdList": ["PMC7534957", "33027419"]}, {"Citation": "Diaz-de-Cerio E., Verardo V., Gomez-Caravaca A.M., Fernandez-Gutierrez A., Segura-Carretero A. Health effects of Psidium guajava L. leaves: an overview of the last decade. Int. J. Mol. Sci. 2017;18(897):1\u201331.", "ArticleIdList": ["PMC5412476", "28441777"]}, {"Citation": "Jusuf E. Quercetin content and proteomic profile of GVXVA (Psidium guajava L.) varieties wild growing in Cibinong and tumbuh liar di kawasan Cibinong, distric Bogor. Berita Biologi. 2020;10:401\u2013415. doi: 10.14203/beritabiologi.v10i3.756.", "ArticleIdList": ["10.14203/beritabiologi.v10i3.756"]}, {"Citation": "Kaul T.N., Middleton E., Ogra P.L. Antiviral effect of flavonoids on human viruses. J. Med. Virol. 1985;15:71\u201379. doi: 10.1002/jmv.1890150110.", "ArticleIdList": ["10.1002/jmv.1890150110", "2981979"]}, {"Citation": "Khalil H.E.L., Maksoud A.I.A., Roshdey T., El Masry S. Guajava flavonoid glycosides prevent influenza A virus infection via rescue of P53 activity. J. Med. Virol. 2017;91:45\u201355. doi: 10.1177/1179069517704668.", "ArticleIdList": ["10.1177/1179069517704668", "30153335"]}, {"Citation": "Khamath J.V., Rahul N., Kumar C.K.A., Laksmi S.M. Psidium guajava L: A review. International Journal of Green Pharmacy. 2008;2:9\u201312. doi: 10.22377/ijgp.v2i1.386.", "ArticleIdList": ["10.22377/ijgp.v2i1.386"]}, {"Citation": "Lara-Guzman O.J., Tabares-Guevara J.H., Leon-Varela Y.M., Alvarez R.M., Roldan M.A., Sierra J.A., Londono-Londono J.A., Ramirez-Pineda J.R. Proatherogenic macrophage activities are targeted by the flavonoid quercetin. J. Pharmacol. Exp. Ther. 2012;343:296\u2013306. doi: 10.1124/jpet.112.196147.", "ArticleIdList": ["10.1124/jpet.112.196147", "22869926"]}, {"Citation": "Lu S.J., Chong F.C. Combining molecular docking and molecular dynamics to predict the binding modes of flavonoid derivatives with the neuraminidase of the 2009 H1N1 influenza A virus. Int. J. Mol. Sci. 2012;13:4496\u20134507. doi: 10.3390/ijms13044496.", "ArticleIdList": ["10.3390/ijms13044496", "PMC3344228", "22605992"]}, {"Citation": "Luo E., Zhang D., Luo H., Liu B., Zhao K., Zhao Y., Bian Y., Wang Y. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province. China. Chin Med. 2020;15:34. doi: 10.1186/s13020-020-00317-x.", "ArticleIdList": ["10.1186/s13020-020-00317-x", "PMC7156896", "32308732"]}, {"Citation": "Naseer S., Hussain S., Naeem N., Pervaiz M., Rahman M. A Phytochemistry and medical value of Psidium Guava. Clin. Phytoscience. 2018;4:32. doi: 10.1186/s40816-018-0093-8.", "ArticleIdList": ["10.1186/s40816-018-0093-8"]}, {"Citation": "Ngwa W., Kumar R., Thomson D., Lyerly W., More R., et al. Potential of Flavonoid-inspired phytomedicines against COVID-19. Molecules. 2020;25(2707):1\u201310. doi: 10.3390/molecules25112707.", "ArticleIdList": ["10.3390/molecules25112707", "PMC7321405", "32545268"]}, {"Citation": "Ortega J.T., Estrada O., Serrano M.L., Contreras W., Orsini G., Poujoi F.H., Rangel H.R. Glycosylated Flavonoids from Psidium guineense as major inhibitors of HIV-1 replication in vitro. Nat. Prod. Commun. 2017;12:7. doi: 10.1177/1934578X1701200712.", "ArticleIdList": ["10.1177/1934578X1701200712", "0"]}, {"Citation": "Pamungkas K.M.N., Dewi P.I.S.L., Tandiono E.K. Potensi Quercetin dalam ekstrak daun Psidium Guava dan Papain dalam ekstrak daun Carica Papaya Linn sebagai terapi demam berdarah Dengue. Essence of Scientific Medical Journal. 2020;2:22\u201328. doi: 10.24843/ESTL.2020.v17.i02.p04.", "ArticleIdList": ["10.24843/ESTL.2020.v17.i02.p04"]}, {"Citation": "Panche A.N., Diwan A.D., Chandra S.R. Flavonoids: an overview. J. Nutr. Sci. 2016;5:1\u201315. doi: 10.1017/jns.2016.41.", "ArticleIdList": ["10.1017/jns.2016.41", "PMC5465813", "28620474"]}, {"Citation": "Savov V.M., Galabov A.S., Tantcheva L.P., Mileva M.M., Pavlova E.L., Stoeva E.S., Braykova A.A. Effects of rutin and quercetin on monooxygenase activities in experimental influenza virus. Exp. Toxicol. Pathol. 2006;58:59\u201364. doi: 10.1016/j.etp.2006.05.002.", "ArticleIdList": ["10.1016/j.etp.2006.05.002", "16793246"]}, {"Citation": "Shabbir A., Butt H.I., Shahzad M., Arshad H.M. Immunostimulatory effect of methanolic leaves extract of Psidium guajava (Guajava) on humoral and cell-mediated immunity in mice. The J. Anim. Plant Sci. 2016;26:1492\u20131500."}, {"Citation": "Somerville V.S., Braakhuis A.J., Hopskhuis W.G. Effect of Flavonoids on upper respiratory tract infections and immune function: a systematic review and meta-analysis. Adv. Nutr. 2016;7:488\u2013497. doi: 10.3945/an.115.010538.", "ArticleIdList": ["10.3945/an.115.010538", "PMC4863266", "27184276"]}, {"Citation": "Sriwilaijaroen N., Fukumoto S., Kumagai K., Hiramatsu H., Odagiri T., Tashiro M., Suzuki Y. Antiviral effects of Psidium guajava Linn. (guajava) tea on the growth of clinical isolated H1N1 viruses: Its role in viral hemagglutination and neuraminidase inhibition. Antivir. Res. 2012;94:139\u2013146. doi: 10.1016/j.antiviral.2012.02.013.", "ArticleIdList": ["10.1016/j.antiviral.2012.02.013", "22453134"]}, {"Citation": "Sudira I.W., Merdani I.M., Qurani S.N. Preliminary phitochemical analysis of Guajava leaves (Psidium guajava L.) as antidiarrheal in Calves. Advances in Tropical Biodiversity and Environmental Sciences. 2019;3:21\u201324. doi: 10.24843/ATBES.2019.v03.i02.p01.", "ArticleIdList": ["10.24843/ATBES.2019.v03.i02.p01"]}, {"Citation": "WHO, 2020. WHO Virtual press conference on COVID-19. https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final.11mar2020.pdf?sfvrsn=cb432bb3_2 (accessed March 16, 2020)."}, {"Citation": "Zandi K., Teoh B.T., Sam S.S., Wong P.F., Mustafa M.R., Abubakar S. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol J. 2011;8:560. doi: 10.1186/1743-422X-8-560.", "ArticleIdList": ["10.1186/1743-422X-8-560", "PMC3271998", "22201648"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "21"}, {"Year": "2023", "Month": "2", "Day": "27"}, {"Year": "2023", "Month": "4", "Day": "4", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "4", "Day": "3", "Hour": "4", "Minute": "27"}, {"Year": "2023", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "7"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37009425", "PMC9988311", "10.1016/j.jsps.2023.02.012", "S1319-0164(23)00042-7"]}}], "PubmedBookArticle": []}